U.S. Communications Stock News

Voyager Technologies (VOYG) remains unprofitable, with no established year-on-year earnings trend so far, as the company has been publicly traded for less than three years. Revenue is forecast to surge 51.5% per year, far outpacing the US market average of 10.5%. However, net margins remain negative and the Price-To-Sales Ratio sits at a steep 10.3x, well above industry and peer benchmarks. With investors focused on whether overhead and costs are being effectively controlled, the company’s...

Addus HomeCare (ADUS) delivered earnings growth of 16.3% over the past year, with a robust five-year compound annual growth rate for earnings of 19.4%. Earnings are forecast to keep climbing at 16.4% per year, outpacing the broader US market average forecast, while net profit margins held steady at 6.4% compared to 6.5% a year ago. Although revenue growth is set to lag the wider market at 7.8% annually, the company’s consistent track record of profitability and favorable valuation relative to...

Syndax Pharmaceuticals (SNDX) remains unprofitable as net losses have widened at 41.3% per year over the past five years. Net profit margins have stayed negative with no track record of high-quality earnings. Looking forward, revenue is forecast to climb 40.4% annually, outpacing the US market. Earnings are projected to surge 72.8% per year with profitability expected within three years. The share price has settled at $15.35, notably below its estimated fair value of $214.76. The company...

Vornado Realty Trust (VNO) has turned profitable, posting a robust 46.1% per year earnings growth rate over the last five years, but recent results were boosted by a one-off gain of $827.3 million. Although net profit margins have moved into positive territory, forecasts now call for earnings to drop sharply by 83.8% per year over the coming three years. Revenue is projected to rise at a slower 3.3% per year, which is behind the broader US market’s 10.5% per year expectation. With profits...

Kontoor Brands (KTB) is forecasting impressive earnings growth of 20.9% per year, outpacing the US market average of 16%. Current net profit margins have compressed to 7.7% from last year's 9.7%, and over the past five years, the company has averaged 12.4% annual earnings growth, despite recent negative momentum. With top-line growth likely but near-term margin pressure evident, investors are weighing this strong outlook against recent softness in profitability. See our full analysis for...

Thinking about Oshkosh stock and whether it’s great value right now? You’re not alone, and the numbers are worth a closer look. After climbing 28.7% year-to-date, Oshkosh’s price has pulled back noticeably with a 12.4% drop over the past week and an 8.4% decline in 30 days, sparking some big questions about what is driving investor sentiment. These moves come amid news highlighting Oshkosh’s contracts in specialty vehicles and changing defense sector demand. Market commentary around shifts...

Ichor Holdings (ICHR) reported continued unprofitability, with losses worsening at an annual rate of 50.5% over the past five years. Yet, with EPS forecast to rise 77.73% per year and a path to profitability expected within three years, investors eye deep value in the company’s notably low 0.6x Price-To-Sales Ratio, especially when compared to US semiconductor peers trading around 5x sales. The setup is clear: the company’s robust projected profit growth competes with lower-than-market...

Harmonic (HLIT) reported a net profit margin of 7.8%, down from 13.6% the previous year, highlighting a decline in profitability. Despite this margin pressure, the company’s revenue is forecast to grow at 8.6% annually, which is slower than the broader US market’s 10.5%. While earnings growth over the last year was negative, Harmonic has posted an impressive 48.6% annualized earnings growth rate over the past five years, demonstrating substantial long-term gains. Looking forward, earnings are...

Fabrinet (FN) reported annual earnings growth of 13.9%, contributing to an impressive five-year average earnings growth rate of 20.1%. Earnings are forecast to rise at 18.66% per year, while revenue is projected to increase 17.4% annually. Both figures are expected to outpace the broader US market’s growth expectations. However, net profit margins narrowed to 9.8% from 10.3% last year, signaling some margin compression worth noting for investors. See our full analysis for Fabrinet. The next...

If you’ve ever wondered whether Upwork is fairly priced, undervalued, or too expensive to buy right now, you’re not alone. It’s the question every savvy investor should ask before hitting “buy.” Upwork shares have gained 23.0% over the past year and are up 7.9% year-to-date, so there’s definitely momentum and changing sentiment to consider. After a wave of headlines spotlighting Upwork’s expanding partnerships with enterprise clients and increased interest in flexible remote work, the...

Ever wondered if Alight could be a hidden gem or is already priced to perfection? If you’re on the hunt for value, you might be surprised by what the numbers reveal. It's been a rollercoaster for Alight’s shareholders. They have seen the stock drop 12.3% in the last week and a staggering 60.0% since the start of the year, signaling a big shift in how the market values the business. Recently, Alight made headlines by entering new partnerships that aim to strengthen its position in the...

CytomX Therapeutics announced it will present initial translational data from its ongoing Phase 1 study of CX-801 in advanced melanoma at the Society for Immunotherapy of Cancer (SITC) 40th Anniversary Annual Meeting, scheduled for November 7-9, 2025, in National Harbor, MD. This upcoming clinical update provides stakeholders with a key opportunity to assess the potential of CytomX's immunotherapy pipeline, possibly shaping future expectations around its development progress and clinical...

Cabaletta Bio (CABA) gained traction after sharing positive updates on its lead therapy, rese-cel, at the American College of Rheumatology Convergence 2025. The company outlined clinical progress in autoimmune disease trials for myositis, systemic sclerosis and lupus. See our latest analysis for Cabaletta Bio. The buzz from Cabaletta Bio’s clinical updates comes after a remarkable stretch for the stock, with a 23% gain in the past month and a significant 94% share price return over 90 days...

BioNTech (BNTX) remains unprofitable, with net losses increasing at an annual rate of 22.1% over the past five years. While revenue is projected to grow just 1.7% per year, which is much slower than the broader US market's 10.5% rate, the company is expected to stay in the red for at least the next three years. Investors may take note of BioNTech trading below analyst price targets, but persistent weak margins and muted growth expectations continue to cloud the overall outlook. See our full...

If you have ever wondered whether Sonos might actually be a value pick hiding in plain sight, you are not alone. Let's get right to the heart of what the numbers and recent headlines reveal. After a 24.7% gain over the last year and a 14.0% lift year-to-date, Sonos stock has certainly caught some fresh attention. However, short-term dips of -4.6% this week and -1.2% over the past month signal there is still some volatility to watch. Recent news has included Sonos’ ongoing efforts to expand...

Wondering if SPS Commerce is a hidden bargain or a value trap? Here is a breakdown of what’s going on with this software stock before you decide whether it deserves a spot on your radar. The stock has caught plenty of attention after plunging by 25.6% this week and over 54% year-to-date. You may be wondering if this volatility hints at risk, opportunity, or both. Recent news around sector-wide shifts in software demand and emerging competitive pressures have added fuel to the fire. Investors...

Sealed Air Corporation recently reported third-quarter 2025 earnings, highlighting a substantial increase in net income to US$255.1 million and diluted earnings per share to US$1.73, compared to the same period last year, with sales remaining largely unchanged at US$1.35 billion. This performance suggests operational efficiencies are compensating for flat revenue, as the company also reaffirmed its full-year earnings guidance despite continued volume pressures in several segments. We’ll...

Affiliated Managers Group (AMG) delivered a net profit margin of 21.8% for the period, down from 31.5% last year, while earnings have grown at an average annual rate of 14% over the past five years. Looking ahead, earnings are forecast to grow at 12.3% per year and revenue at 5.7% per year. Both metrics trail the broader US market’s pace. With shares trading slightly below estimated fair value and high-quality earnings supporting the story, questions around profit margin direction are likely...

Wondering if Polaris is undervalued or just misunderstood? If you have questions about whether this might be the right time to look closer at the stock, you are in the right place. Polaris shares have climbed 16.4% year-to-date, though they slipped 7.8% over the past week and remain 2.2% below where they were one year ago. Much of this movement has followed management shakeups and noteworthy product launches. These events have caught both investor and industry attention...

Wondering if Jefferson Capital is a hidden bargain or just fairly priced? Let's break things down from a value perspective together. This month, Jefferson Capital's share price has climbed 5.7% despite a slight 1.4% dip over the past week. This may indicate that investor sentiment is shifting and growth potential could be back on the radar. Much of this movement follows recent headlines highlighting the company's successful expansion into new regulated markets, as well as a flurry of analyst...

Ever wondered if Jacobs Solutions is truly trading at a bargain or if the market has it priced just right? Let’s take a closer, no-nonsense look at where it might stand today. The stock is up an impressive 93.5% over the past five years and still holds a 16.0% gain year-to-date, despite a slight dip of 4.2% in the past week. Markets have taken notice of Jacobs Solutions as headlines cite its expansion into infrastructure modernization projects and recent high-profile contract wins. This has...

Curious if Hertz Global Holdings is a bargain or a bounce trap? You're not alone, and we're diving deep to see just how much value might be hiding in the numbers. The stock has rocketed up 32.4% year to date and gained an impressive 69.8% over the past year, even though it has dipped 4.4% in the last week and 21.0% over the past month. Momentum has largely been sparked by renewed attention on the used car market and shifting consumer travel habits, both of which put Hertz in the spotlight...

Heritage Insurance Holdings Inc will report its Q3 2025 earnings on November 5, 2025, following a quarter where its actual earnings per share significantly surpassed analyst expectations even as revenue came in below estimates. This divergence between stronger-than-expected earnings and softer revenue projections, alongside upward earnings estimate revisions and declining revenue forecasts for 2025 and 2026, has driven increased investor attention ahead of the upcoming results. We will...

Marathon Petroleum Corporation's ( NYSE:MPC ) periodic dividend will be increasing on the 10th of December to $1.00...